4//SEC Filing
Papiernik Antoine 4
Accession 0001209191-22-046119
CIK 0001642545other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 8:05 PM ET
Size
32.6 KB
Accession
0001209191-22-046119
Insider Transaction Report
Form 4
Papiernik Antoine
Director10% Owner
Transactions
- Sale
Common Stock
2022-08-12$283.83/sh−6,217$1,764,571→ 50,097 total(indirect: By Sofinnova Capital VII FCPR) - Sale
Common Stock
2022-08-12$285.08/sh−1,574$448,716→ 48,523 total(indirect: By Sofinnova Capital VII FCPR) - Sale
Common Stock
2022-08-12$292.29/sh−2,023$591,303→ 13,443 total(indirect: By Sofinnova Capital VII FCPR) - Sale
Common Stock
2022-08-12$287.14/sh−2,954$848,212→ 43,856 total(indirect: By Sofinnova Capital VII FCPR) - Sale
Common Stock
2022-08-12$280.66/sh−500$140,330→ 61,751 total(indirect: By Sofinnova Capital VII FCPR) - Sale
Common Stock
2022-08-12$282.22/sh−2,937$828,880→ 58,814 total(indirect: By Sofinnova Capital VII FCPR) - Sale
Common Stock
2022-08-12$283.27/sh−2,500$708,175→ 56,314 total(indirect: By Sofinnova Capital VII FCPR) - Sale
Common Stock
2022-08-12$288.37/sh−2,739$789,845→ 41,117 total(indirect: By Sofinnova Capital VII FCPR) - Sale
Common Stock
2022-08-12$293.03/sh−1,192$349,292→ 12,251 total(indirect: By Sofinnova Capital VII FCPR) - Sale
Common Stock
2022-08-12$286.38/sh−1,713$490,569→ 46,810 total(indirect: By Sofinnova Capital VII FCPR) - Sale
Common Stock
2022-08-12$290.33/sh−7,585$2,202,153→ 23,947 total(indirect: By Sofinnova Capital VII FCPR) - Sale
Common Stock
2022-08-12$289.26/sh−9,585$2,772,557→ 31,532 total(indirect: By Sofinnova Capital VII FCPR) - Sale
Common Stock
2022-08-12$291.35/sh−8,481$2,470,939→ 15,466 total(indirect: By Sofinnova Capital VII FCPR)
Holdings
- 4,545
Common Stock
Footnotes (14)
- [F1]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $280.25 to $280.86. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F10]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $288.79 to $289.79. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F11]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $289.85 to $290.83. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F12]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $290.87 to $291.87. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F13]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $291.90 to $292.75. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F14]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $292.91 to $293.15. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F2]Represents shares directly held by Sofinnova Capital VII FCPR. The reporting person is one of the managing partners of Sofinnova Partners SAS, a French corporation and the management company of Sofinnova Capital VII FCPR. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.
- [F3]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $281.49 to $282.44. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F4]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $282.50 to $283.50. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F5]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $283.51 to $284.51. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F6]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $284.52 to $285.27. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F7]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $285.69 to $286.67. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F8]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $286.72 to $287.71. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F9]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $287.76 to $288.75. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Documents
Issuer
Shockwave Medical, Inc.
CIK 0001642545
Entity typeother
Related Parties
1- filerCIK 0001768408
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 8:05 PM ET
- Size
- 32.6 KB